Literature DB >> 7076746

High-performance liquid chromatographic method for the quantitative analysis of the aryloxypropanolamines propranolol, metoprolol and atenolol in plasma and tissue.

H Winkler, W Ried, B Lemmer.   

Abstract

A simple and rapid high-performance liquid chromatographic method is described for the quantitative analysis of three beta-receptor blocking drugs of similar molecular structure (aryloxypropanolamines, AOPAs) but with different polarities. the method consists of extraction, reversed-phase ion-pair chromatography and fluorometric detection, whereby slight modifications in these parameters allow analysis of the different AOPAs in a similar way. The method was used to determine concentrations of propranolol, metoprolol and atenolol in plasma and various organs of the rat. In samples of 1 ml of plasma and 0.5--1.7 g of tissue, drug concentrations of at least 2 ng/ml and 5 ng/g, respectively, can be measured. Extension of the method to other AOPAs is possible.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7076746     DOI: 10.1016/s0378-4347(00)80435-1

Source DB:  PubMed          Journal:  J Chromatogr


  6 in total

1.  Central effects of beta-adrenoceptor antagonists. I--Performance and subjective assessments of mood.

Authors:  D Currie; R V Lewis; D G McDevitt; A N Nicholson; N A Wright
Journal:  Br J Clin Pharmacol       Date:  1988-08       Impact factor: 4.335

2.  Circadian changes in the pharmacokinetics and cardiovascular effects of oral propranolol in healthy subjects.

Authors:  B Langner; B Lemmer
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat.

Authors:  B Lemmer; H Winkler; T Ohm; M Fink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-07       Impact factor: 3.000

4.  Stereospecific high-performance liquid chromatographic assay of sotalol in plasma.

Authors:  R A Carr; R T Foster; N H Bhanji
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

5.  Central effects of the angiotensin-converting enzyme inhibitor, captopril. I. Performance and subjective assessments of mood.

Authors:  D Currie; R V Lewis; D G McDevitt; A N Nicholson; N A Wright
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

6.  Central effects of repeated administration of atenolol and captopril in healthy volunteers.

Authors:  D G McDevitt; D Currie; A N Nicholson; N A Wright; M B Zetlein
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.